BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25730220)

  • 1. Association of body mass index and morbidity after abdominal, vaginal, and laparoscopic hysterectomy.
    Shah DK; Vitonis AF; Missmer SA
    Obstet Gynecol; 2015 Mar; 125(3):589-598. PubMed ID: 25730220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Body Mass Index, Uterine Size, and Operative Morbidity in Women Undergoing Minimally Invasive Hysterectomy.
    Shah DK; Van Voorhis BJ; Vitonis AF; Missmer SA
    J Minim Invasive Gynecol; 2016; 23(7):1113-1122. PubMed ID: 27523922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
    Chong W; Bui AH; Menhaji K
    Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trainee participation and perioperative complications in benign hysterectomy: the effect of route of surgery.
    Barber EL; Harris B; Gehrig PA
    Am J Obstet Gynecol; 2016 Aug; 215(2):215.e1-7. PubMed ID: 26884272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the national surgical quality improvement program data.
    Mahdi H; Goodrich S; Lockhart D; DeBernardo R; Moslemi-Kebria M
    J Minim Invasive Gynecol; 2014; 21(5):901-9. PubMed ID: 24768957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Postoperative Morbidity among Obese Patients Undergoing Abdominal Versus Laparoscopic Hysterectomy for Benign Indications.
    Tyan P; Amdur R; Berrigan M; Robinson H; Sparks A; Gu A; Wei C; Klebanoff J; Moawad G
    J Minim Invasive Gynecol; 2020 Feb; 27(2):464-472. PubMed ID: 30965116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing Risks in Minimally Invasive Surgery: Rates of Surgical Site Infection Across Subtypes of Laparoscopic Hysterectomy.
    Brown O; Geynisman-Tan J; Gillingham A; Collins S; Lewicky-Gaupp C; Kenton K; Mueller M
    J Minim Invasive Gynecol; 2020; 27(6):1370-1376.e1. PubMed ID: 31672589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer Operative Time During Benign Laparoscopic and Robotic Hysterectomy Is Associated With Increased 30-Day Perioperative Complications.
    Catanzarite T; Saha S; Pilecki MA; Kim JY; Milad MP
    J Minim Invasive Gynecol; 2015; 22(6):1049-58. PubMed ID: 26070725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Bowel Injury in Hysterectomy for Benign Indications.
    Zhu CR; Mallick R; Singh SS; Auer R; Solnik J; Choudhry AJ; Chen I
    Obstet Gynecol; 2020 Oct; 136(4):803-810. PubMed ID: 32925612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.
    Louie M; Strassle PD; Moulder JK; Dizon AM; Schiff LD; Carey ET
    Am J Obstet Gynecol; 2018 Nov; 219(5):480.e1-480.e8. PubMed ID: 29959931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of complication at the time of laparoscopic hysterectomy: a prediction model built from the National Surgical Quality Improvement Program database.
    Pepin KJ; Cook EF; Cohen SL
    Am J Obstet Gynecol; 2020 Oct; 223(4):555.e1-555.e7. PubMed ID: 32247844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the modifiable life-style factors body mass index and smoking on the outcome of hysterectomy.
    Bohlin KS; Ankardal M; Stjerndahl JH; Lindkvist H; Milsom I
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):65-73. PubMed ID: 26459279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of length of surgery on the incidence of venous thromboembolism after benign hysterectomy.
    Moulder JK; Moore KJ; Strassle PD; Louie M
    Am J Obstet Gynecol; 2021 Apr; 224(4):364.e1-364.e7. PubMed ID: 33039394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Well-Being and Route of Benign Hysterectomy.
    Waldman I; Wagner S; Kulaylat AS; Deimling TA
    Womens Health Issues; 2018; 28(5):456-461. PubMed ID: 30177340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of and Reasons for Unplanned 30-Day Readmission After Hysterectomy for Benign Disease.
    Penn CA; Morgan DM; Rice LW; Harris JA; Rauh-Hain JA; Uppal S
    Obstet Gynecol; 2016 Oct; 128(4):889-897. PubMed ID: 27607868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of venous thromboembolism in abdominal versus minimally invasive hysterectomy for benign conditions.
    Barber EL; Neubauer NL; Gossett DR
    Am J Obstet Gynecol; 2015 May; 212(5):609.e1-7. PubMed ID: 25511239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between obesity and the trends of routes of hysterectomy performed for benign indications.
    Mikhail E; Miladinovic B; Velanovich V; Finan MA; Hart S; Imudia AN
    Obstet Gynecol; 2015 Apr; 125(4):912-918. PubMed ID: 25751208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous Thromboembolism After Abdominal and Minimally Invasive Large Specimen Hysterectomy.
    Pham NK; Jalloul RJ; Chen HY; Hui M; Leon MG
    J Minim Invasive Gynecol; 2023 Nov; 30(11):884-889. PubMed ID: 37422052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical site infection after hysterectomy.
    Lake AG; McPencow AM; Dick-Biascoechea MA; Martin DK; Erekson EA
    Am J Obstet Gynecol; 2013 Nov; 209(5):490.e1-9. PubMed ID: 23770467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and Perioperative Outcomes across Elective Benign Hysterectomy Procedures from the ACS-NSQIP 2007-2017.
    Tyan P; Hawa N; Carey E; Urbina P; Chen FR; Sparks A; Amdur R; Moawad G
    J Minim Invasive Gynecol; 2022 Mar; 29(3):365-374.e2. PubMed ID: 34610464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.